A prospective study in gynaecology clinics was conducted in Abidjan, Côte d'Ivoire, to assess the short-term evolution of squamous intraepithelial lesions (SILs). Of 94 women with a cytological diagnosis of SIL, 38 were infected with HIV. The average follow-up period after the initial smear was 5 months. Detection of human papillomavirus (HPV) by polymerase chain reaction (PCR) was performed at both the time of enrolment and final follow-up smear. There were 39 cases of persistent SILs. HIV-positive women had a higher percentage of persistent SIL (76%) than HIV-negative women (18%, relative risk (RR)=4.3, 95% confidence interval (CI)=2.4, 7.7). SILs were more frequent among women infected with HPV at the time of enrolment or with persistent HPV infection, but these associations disappeared after adjusting for HIV serostatus. Spontaneous regression of SILs commonly occurs in HIV-negative African women. HIV-infected women with cervical dyskaryosis require gynaecology follow-up.
ParkinD.M., LääräE., MuirC.S.Estimates of the worldwide frequency of sixteen major cancers in 1980.Int J Cancer1988; 41: 184–97.
2.
KoulibalyM., KabbaI.S., CisséA.Cancer incidence in Conakry, Guinea: first results from the cancer registry 1992–1995.Int J Cancer1997; 70: 39–45.
3.
Ter MeulenJ., EberhardtH.C., LuandeJ.Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa.Int J Cancer1992; 51: 515–21.
4.
BoschF.X., ManosM.M., MuñozN.Prevalence of human papillomavirus in cervical cancer: a worldwide perspective.J Natl Cancer Inst1995; 87: 796–802.
5.
LagaM., IcenogleJ.P., MarsellaR.Genital papillomavirus infection and cervical dysplasia — opportunistic complications of HIV infection.Int J Cancer1992; 50: 45–8.
6.
MaggwaB.N., HunterD.J., MbuguaS., TukeiP., MatiJ.K.The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.AIDS1993; 7: 733–8.
7.
Coll SeckA., FayeM.A., CritchlowC.W.Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.Int J STD AIDS1994; 5: 189–93.
8.
WrightT.C., KurmanR.J.A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm.Papillomavirus Rep1994; 5: 175–82.
9.
KataseK., TeshimaH., HiraiY., HasumiK.Natural history of cervical human papillomavirus lesions.Intervirology1995; 38: 192–4.
10.
HoG.Y.F., BurkR.D., KleinR.S.Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.J Natl Cancer Inst1995; 87: 1365–71.
11.
RemminkA.J., WalboomersJ.M., HelmerhorstT.J.The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.Int J Cancer1995; 61: 306–11.
12.
HeardI., BergeronC., JeannelD., HenrionR., KazatchkineM.D.Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up.Obstet Gynecol1995; 86: 749–53.
13.
FruchterR.G., MaimanM., SedlisA., BartleyL., CamilienL., ArrastiaC.D.Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus.Obstet Gynecol1996; 87: 338–44.
14.
SunX.W., KuhnL., EllerbrockT.V., ChiassonM.A., BushT.J., WrightT.C.Human papillomavirus infection in women infected with the human immunodeficiency virus.N Engl J Med1997; 337: 1343–9.
15.
La RucheG., RamonR., Mensah-AdoI.Squamous intraepithelial lesions of the cervix, invasive cervical cancer and human immunodeficiency virus-induced immunosuppression in Africa.Cancer1998; 82: 2401–8.
16.
National Cancer Institute Workshop.The Bethesda system for reporting cervical/vaginal cytologic diagnoses.Acta Cytol1993; 37: 115–24.
17.
ManosM.M., TingY., WrightD.K., LewisA.J., BrokerT.R., WolinskyS.M.Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses.Cancer Cells1989; 7: 209–14.
18.
BernardH.U., ChanS.Y., ManosM.M.Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.J Infect Dis1994; 170: 1077–85.
19.
NasiellK., RogerV., NasiellM.Behaviour of mild cervical dysplasia during long-term follow-up.Obstet Gynecol1986; 67: 665–9.
20.
SchiffmanM.H., BrintonL.A.The epidemiology of cervical carcinogenesis.Cancer1995; 76: 1888–901.
21.
KoutskyL.A., HolmesK.K., CritchlowC.W.A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.N Engl J Med1992; 327: 1272–8.
22.
La RucheG., YouB., Mensah-AdoI.Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.Int J Cancer1998; 76: 480–6.
23.
ChuaK.L., HjerpeA.Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma.Cancer1996; 77: 121–7.
24.
BollenL.J., Tjong-A-HungS.P., van der VeldenJ.Human papillomavirus DNA after treatment of cervical dysplasia: low prevalence in normal cytologic smears.Cancer1996; 77: 2538–43.
25.
HerringtonC.S., EvansM.F., CharnockF.M., GrayW., O'D McGeeJ.HPV testing in patients with low grade cervical cytological abnormalities: a follow up study.J Clin Pathol1996; 49: 493–6.
26.
CampionM.J., CuzickJ., McCanceD.J., SingerA.Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study.Lancet1986; ii: 237–40
27.
WoodmanC.B., RollasonT., EllisJ., TierneyR., WilsonS., YoungL.Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix.Br J Cancer1996; 73: 553–6.
28.
BrissonJ., BairatiI., MorinC.Determinants of persistent detection of human papillomavirus DNA in the uterine cervix.J Infect Dis1996; 173: 794–9.
29.
HildesheimA., SchiffmanM.H., GravittP.E.Persistence of type-specific human papillomavirus infection among cytologically normal women.J Infect Dis1994; 169: 235–40.
